Back to Research

Organization profile

BioMedPartners

BioMedPartners is a Basel-based venture capital firm that provides equity and mezzanine financing to early- and mid-stage healthcare and life science companies in the Alpine region. The firm focuses on biopharmaceuticals, medical devices, and diagnostics, leveraging a deep network and industry expertise to build innovative healthcare companies.

Basel, SwitzerlandFounded 2002

Overview

1. Executive Summary (Confidence: High)

BioMedPartners has established itself as one of the most prominent venture capital firms in the European healthcare sector, particularly within the Switzerland-Germany-Austria "Alpine Rim". Since its inception in 2002, the firm has managed several funds, including the CHF 100 million BioMedInvest III, supporting more than 65 companies across the biotechnology and medical technology landscapes. BioMedPartners typically takes a lead or co-lead investor role, providing not only capital but also active strategic guidance through board representation. The firm is led by a team of industry veterans, including General Partners Dr. Markus Hosang and Dr. Michael Wacker, who bring extensive backgrounds in drug development, finance, and corporate leadership at firms like Roche.

Unlock the full profileGet the complete company dossier

This public view only shows an extract. Open the full profile to access the complete company intelligence record, including the full write-up and structured research details.

Desktop only

Research is currently available on desktop only.

The Research module is designed for larger screens. Please reopen it on a desktop or laptop to use the screener, filters, detail pages, and admin tools.